side effects Tagged Articles

FDA approves new type 2 diabetes drug Tanzeum

Posted: April 18, 2014 Pharmaceutical

After a three-month delay, the Food and Drug Administration (FDA) has approved GlaxoSmithKline’s new type 2 diabetes treatment, albiglutide. The drug will be marketed in the United States as Tanzeum.

Cases of diabetes on the rise in the United States

Posted: April 17, 2014 Pharmaceutical

The number of Americans with diabetes has nearly doubled in the past 20 years, paralleling the country’s growing obesity epidemic. Experts say if the trend continues, the number of Americans with diabetes will reach 44 million in the next 20

FDA delays decision on diabetes inhaler to review possible cancer risks

Posted: April 11, 2014 Pharmaceutical

The Food and Drug Administration (FDA) has delayed its decision about whether to approve Mannkind Corp.’s Afrezza, an inhaled insulin treatment for diabetes, due to concerns about an increased risk of lung cancer.

Zohydro maker files lawsuit to block Massachusetts governor’s ban

Posted: April 10, 2014 Pharmaceutical

Less than a week after Massachusetts governor Deval Patrick banned the sale of the controversial new potent painkiller Zohydro, the drug’s maker has filed a lawsuit aimed at blocking the governor’s request.

EPA human test subjects were not always told of cancer, death risks

Posted: April 8, 2014 Personal Injury

The Environmental Protection Agency (EPA) is being strongly encouraged to overhaul its guidelines for human test subjects after an investigation found that many of the people signed up to test the impact of pollutants for the agency were not always

Dramatic increase in poison center calls regarding e-cigarettes encourages stronger government oversight

Posted: April 7, 2014 Personal Injury

The number of calls to poison centers regarding e-cigarette liquids containing nicotine has increased dramatically in recent years from just one a month in 2010 to 215 a month so far in 2014, according to the Centers for Disease Control

FDA plans to encourage more diversity in drug and medical device testing

Posted: April 5, 2014 Pharmaceutical

The Food and Drug Administration (FDA) wants drug companies to be more diligent at recruiting more diverse populations for clinical trials, and is launching an action plan to assist with this effort, agency commissioner Margaret A. Hamburg said.

Justice group supports holding generic drug companies liable for side effects

Posted: April 4, 2014 Pharmaceutical

Authorizing manufacturers of generic drugs to update safety labels independently, without waiting for Food and Drug Administration (FDA) approval or for the brand name equivalent to change its label, is a sensible rule proposed by the FDA and will give

FDA chief fields tough questions about proposed new labeling rule for generic drug makers

Posted: April 2, 2014 Pharmaceutical

Food and Drug Administration (FDA) commissioner Margaret Hamburg last week fielded tough questions from a Congressional committee regarding a controversial proposed rule that would allow generic drug makers to update their warning labels beyond what the brand name lists on

Teenager warns others about humiliating Risperidal side effect

Posted: April 1, 2014 Pharmaceutical

Sam Wilson tried for years to hide the humiliating side effect he developed while taking the antipsychotic drug Risperdal. But now the teenager is ready to speak out in an effort to warn boys taking the drug.